The biotechnology giant Monsanto has now partnered with the Broad Institute to develop seeds using genetic or genome editing technology. On Thursday, Monsanto announced a new partnership with the Broad Institute, a project of MIT and Harvard that focuses on a biomedical and genomic research. The new partnership grants Monsanto non-exclusive licensing for agriculture applications of CRISPR-Cas Read More…